Insulin treatment improves islet function in type 2 diabetic Chinese hamsters.

Area of Science:

• Endocrinology
• Metabolic Diseases
• Cell Biology

Background:

• Long-standing type 2 diabetes is characterized by hyperglycemia and impaired pancreatic islet function.
• Understanding how glycemic control impacts islet cell function is crucial for developing effective diabetes treatments.

Purpose of the Study:

• To investigate whether normalizing hyperglycemia improves islet function in a genetic model of type 2 diabetes.
• To assess the effects of glycemic normalization on glucose-stimulated insulin secretion, cyclic AMP signaling, insulin content, and beta cell morphology.

Main Methods:

• Hyperglycemic CHIG/Han diabetic Chinese hamsters were treated with insulin implants or vehicle for two weeks.
• Islets were isolated and subjected to glucose-stimulated insulin secretion assays with and without IBMX (3-isobutyl-1-methylxanthine).
• Immunocytochemical analysis was performed to assess insulin cell morphology and staining.

Main Results:

• Diabetic hamsters showed significantly reduced glucose-stimulated insulin secretion and impaired IBMX potentiation compared to controls.
• Two weeks of insulin treatment normalized the relationship between IBMX-potentiated and glucose-stimulated insulin secretion.
• Insulin treatment increased islet insulin content and improved beta cell degranulation and insulin staining.

Conclusions:

• Two weeks of glycemic normalization in long-standing type 2 diabetes improves beta cell signaling via the cyclic AMP pathway.
• Glycemic control enhances islet insulin content and restores beta cell morphology in diabetic Chinese hamsters.
• These findings highlight the potential of glycemic normalization to reverse functional and structural deficits in pancreatic islets in type 2 diabetes.